Zavedos® 5 mg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung Wirkstoff: Idarubicinhydrochlorid clinical trials

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020

This study looks at new ways to treat children with a type of blood cancer called B-cell acute lymphoblastic leukaemia, which has come back after earlier treatment. It compares different drug combinations to find the most effective and safest options for them.